Skip to main content
VMD
NASDAQ Industrial Applications And Services

Viemed Posts Record $80.7M Q3 Revenue, Lifts Low End of 2026 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.05
Mkt Cap
$385.072M
52W Low
$6.05
52W High
$12.61
52W Position info
66% above low
Off High info
20% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

VMD sits 66% above its 52-week low of $6.05.

Summary

Viemed reported record Q3 2026 revenue of $80.7 million and net income of $4.6 million, up 67.8% sequentially, and raised the low end of its full-year revenue guidance to $316 million.


Key Events · Earnings and Guidance · VMD

  • Record Q3 Revenue of $80.7M

    Revenue rose 12.2% year over year and 3.3% sequentially, the first full quarter with Lehan in both comparison periods.

  • Profitability Jumped Sequentially

    Net income attributable to Viemed was $4.6 million ($0.11 per diluted share), up 67.8% from Q2, and Adjusted EBITDA rose 24.4% to $17.1 million, or 21.1% of revenue versus 17.6% in Q2.

  • Guidance Low End Raised

    Full-year 2026 revenue guidance is now $316 million-$320 million (low end up from $314 million), Adjusted EBITDA narrowed to $64 million-$66 million, and net capex lowered to 8.0%-9.0% of revenue.

  • Sleep Segment Driving Growth

    PAP therapy patients grew 37.5% year over year to 43,861 and sleep resupply patients 22.1% to 40,918, while ventilator rental revenue rose 7.4% to $37.5 million.


Analysis · VMD · Industrial Applications And Services

The headline is a record quarter, but the sharper signal is the sequential profitability jump: net income rose 67.8% and Adjusted EBITDA 24.4% from Q2, lifting Adjusted EBITDA margin to 21.1% from 17.6%. Management raised the low end of its revenue range to $316 million and narrowed Adjusted EBITDA to $64 million-$66 million, while cutting capex intensity to 8.0%-9.0% of revenue, which supports free cash flow. With no net debt and $46 million available on its credit facilities, this is growth funded internally rather than by dilution.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VMD was trading at $10.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $385.1M. The 52-week trading range was $6.05 to $12.61. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VMD - Latest Insights

VMD
Nov 04, 2026, 5:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $8.61 info
Change: -$1.44 (-14%) info
Market Cap: $326.26M info
VMD
Nov 04, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $10.05
Real-time Price: $8.61 info
Change: -$1.44 (-14%) info
Market Cap: $326.26M info
VMD
Aug 20, 2026, 5:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.57
Real-time Price: $8.61 info
Change: +$0.040 (+0.47%) info
Market Cap: $326.26M info
VMD
Aug 03, 2026, 5:23 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $8.61 info
Change: -$2.39 (-22%) info
Market Cap: $326.26M info
VMD
Aug 03, 2026, 5:04 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.00
Real-time Price: $8.61 info
Change: -$2.39 (-22%) info
Market Cap: $326.26M info